An opioid treatment clinic in Vermont
Jordan Silverman/Getty
Early in August, the US Food and Drug Administration (FDA) approved a sixth medication for reversing opioid overdoses. The product, call Zurnai, is an automatic injection of the drug nalmefene, produced by Purdue Pharma – the same pharmaceutical company that helped fuel the opioid crisis.
Irony aside, this is – at least at face value – a welcome addition to the growing arsenal of medications meant to combat the opioid crisis. Nalmefene is stronger and has a longer duration than its more common counterpart naloxone, which has become less effective against an…
Felecia Phillips Ollie DD (h.c.) is the inspiring leader and founder of The Equality Network LLC (TEN). With a background in coaching, travel, and a career in news, Felecia brings a unique perspective to promoting diversity and inclusion. Holding a Bachelor’s Degree in English/Communications, she is passionate about creating a more inclusive future. From graduating from Mississippi Valley State University to leading initiatives like the Washington State Department of Ecology’s Equal Employment Opportunity Program, Felecia is dedicated to making a positive impact. Join her journey on our blog as she shares insights and leads the charge for equity through The Equality Network.
